The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A comparison study of the intratumoral microbiome in younger verses older-onset colorectal cancer (COSMO CRC).
 
Benjamin Adam Weinberg
Honoraria - Onclive; Onclive; Onclive; Onclive; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Tempus; Tempus; Tempus; Tempus
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Lilly; Lilly; Lilly; Lilly; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Isofol Medical (Inst); Isofol Medical (Inst); Isofol Medical (Inst); Isofol Medical (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences
 
Hongkun Wang
No Relationships to Disclose
 
Xue Geng
No Relationships to Disclose
 
Shadi Shokralla
Employment - Clear Labs; Clear Labs; Clear Labs; Clear Labs
 
Emily Bakhshi
No Relationships to Disclose
 
Krysta Chaldekas
Employment - DJO (I); DJO (I); DJO (I); DJO (I)
Stock and Other Ownership Interests - DJO (I); DJO (I); DJO (I); DJO (I)
Consulting or Advisory Role - DJO (I); DJO (I); DJO (I); DJO (I)
Speakers' Bureau - DJO (I); DJO (I); DJO (I); DJO (I)
Travel, Accommodations, Expenses - DJO (I); DJO (I); DJO (I); DJO (I)
 
Brent T. Harris
No Relationships to Disclose
 
Dionyssia Clagett
No Relationships to Disclose
 
John Marshall
Employment - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences
Honoraria - Amgen; Amgen; Amgen; Amgen; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Celgene; Celgene; Celgene; Celgene; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Celgene; Celgene; Celgene; Celgene; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Celgene; Celgene; Celgene; Celgene; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)